Lab
Paradigm Laboratories, LLC
Paradigm Laboratories, LLC was paid $192K by Medicaid between May 2018 and Feb 2022, across 38 billing codes. Its largest line is 0012A, — 21% of everything it billed.
33Billing provider infoPARADIGM LABORATORIES, LLC
TUCSON, AZ 85712
TUCSON, AZ 85712
33aNPI1801291414assigned 10/24/2014
33bProvider typeClinical Medical Laboratory
28Total paid$192K
24GClaims8,341
24DCodes billed38
24AFirst – last monthMay 2018 – Feb 2022
Compared with peers
Next to other Clinical Medical Laboratory providers in Arizona
Rank by total paid#30 of 67
Median peer was paid$89K
This provider vs. median2.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 204 | $425.18 | |
| 2019 | 937 | $10K | |
| 2020 | 288 | $9K | |
| 2021 | 6,698 | $162K | |
| 2022 | 214 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0012A | 21% | 1,636 | 1,153 | $40K | |
| 0002A | 21% | 1,121 | 806 | $39K | |
| 0001A | 19% | 1,066 | 780 | $36K | |
| 0011A | 18% | 1,541 | 1,156 | $35K | |
| 0064A | 5.0% | 148 | 141 | $10K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.6% | 76 | 12 | $7K |
| 0031A | 2.4% | 102 | 100 | $5K | |
| 0071A | 1.9% | 46 | 46 | $4K | |
| 0004A | 1.6% | 43 | 43 | $3K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 336 | 318 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 421 | 399 | $1K |
| 0034A | <1% | 12 | 12 | $747.04 |
26 more codes
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 46 | $590.50 |
| 80348 | <1% | 33 | $517.50 | |
| 80373 | <1% | 33 | $517.50 | |
| 80365 | <1% | 33 | $517.50 | |
| 80354 | <1% | 33 | $517.50 | |
| 80347 | <1% | 33 | $517.50 | |
| 80356 | <1% | 33 | $517.50 | |
| 80361 | <1% | 33 | $517.50 | |
| 80358 | <1% | 33 | $517.50 | |
| 80363 | <1% | 33 | $517.50 | |
| 80324 | <1% | 33 | $517.50 | |
| 83992 | <1% | 20 | $352.44 | |
| 80338 | <1% | 20 | $310.50 | |
| 80336 | <1% | 20 | $310.50 | |
| 80360 | <1% | 20 | $310.50 | |
| 80342 | <1% | 20 | $310.50 | |
| 80369 | <1% | 20 | $310.50 | |
| 80332 | <1% | 20 | $310.50 | |
| 80323 | <1% | 20 | $310.50 | |
| 80359 | <1% | 20 | $310.50 | |
| 80357 | <1% | 20 | $310.50 | |
| 80353 | <1% | 20 | $310.50 | |
| 91300 | <1% | 436 | $0.17 | |
| 91306 | <1% | 51 | $0.16 | |
| 91301 | <1% | 695 | $0.13 | |
| 91307 | <1% | 15 | $0.09 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSASZ, ETHAN (MANAGING MEMBER)